Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Huayu Tonifying kidney granules is a Traditional Chinese Medicine (TCM) herbal formula developed by the Department of Orthopedics at Longhua Hospital, Shanghai University of Traditional Chinese Medicine. It is indicated for the treatment of mild to moderate cervical spondylotic myelopathy (CSM). The formula is designed based on TCM principles to replenish Qi (Yiqi), resolve blood stasis (Huayu), and tonify the kidney (Bushen), aiming to improve spinal cord function and alleviate symptoms associated with chronic spinal cord compression. It is typically administered orally in a granule dosage form and has been studied in randomized, placebo-controlled clinical trials in China to evaluate its safety and therapeutic efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi Huayu Tonifying kidney granules.